Suppr超能文献

动静脉内瘘钙化——危险因素及临床意义

Arterio-Venous Fistula Calcifications-Risk Factors and Clinical Relevance.

作者信息

Grosu Iulia Dana, Stirbu Oana, Schiller Adalbert, Bob Flaviu

机构信息

Department of Internal Medicine II-Nephrology University Clinic, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.

Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.

出版信息

Biomedicines. 2024 Oct 27;12(11):2464. doi: 10.3390/biomedicines12112464.

Abstract

(1) Background: Arterio-venous fistulas (AVFs) are considered the gold-standard vascular access (VA) in patients on maintenance hemodialysis (HD) therapy. AVF calcifications represent a less studied VA related complication, even though HD patients are at a higher risk for extraosseous calcifications. The aim of this study is to assess the prevalence and risk factors of AVF calcifications, as well as the 5-year impact on AVF functionality and on overall mortality. (2) Methods: We conducted a 5-year prospective study including 161 patients on maintenance HD therapy. At baseline, we collected data related to VA history, comorbidities, demographics, subjective global assessment scale (SGA), and biochemical parameters. All patients underwent a complete AVF ultrasound and we recorded AVF blood flow and the presence of AVF calcifications, stenoses, and aneurysms. (3) Results: In our study, we found an AVF calcification prevalence of 39%. In a univariate analysis, we found that patients with AVF calcifications were associated with other AVF complications as well (stenoses, aneurysms), had longer AVF and HD vintage, as well as higher serum calcium and PTH values. In a multivariate analysis, we found that patients with a longer HD vintage and higher calcium values were independently associated with AVF calcifications. AVF calcifications did not affect 5-year fistula patency, nor were they associated with a higher mortality risk in our group of patients. (4) Conclusions: AVF calcifications were a frequent finding in our analysis, but their presence does not seem to affect the 5-year AVF patency.

摘要

(1) 背景:动静脉内瘘(AVF)被认为是维持性血液透析(HD)治疗患者血管通路(VA)的金标准。尽管HD患者发生骨外钙化的风险较高,但AVF钙化是一种研究较少的与VA相关的并发症。本研究的目的是评估AVF钙化的患病率和危险因素,以及其对AVF功能和总体死亡率的5年影响。(2) 方法:我们进行了一项为期5年的前瞻性研究,纳入161例维持性HD治疗患者。在基线时,我们收集了与VA病史、合并症、人口统计学、主观全面评定量表(SGA)和生化参数相关的数据。所有患者均接受了完整的AVF超声检查,我们记录了AVF血流量以及AVF钙化、狭窄和动脉瘤的存在情况。(3) 结果:在我们的研究中,我们发现AVF钙化的患病率为39%。在单因素分析中,我们发现有AVF钙化的患者也与其他AVF并发症(狭窄、动脉瘤)相关,有更长的AVF和HD使用时间,以及更高的血清钙和甲状旁腺激素(PTH)值。在多因素分析中,我们发现HD使用时间较长和钙值较高的患者与AVF钙化独立相关。AVF钙化不影响5年内瘘的通畅率,在我们的患者组中也与较高的死亡风险无关。(4) 结论:在我们的分析中,AVF钙化是一个常见的发现,但它们的存在似乎并不影响AVF的5年通畅率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226b/11591894/ab4cb173b954/biomedicines-12-02464-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验